InsidersTradesSigma
DocMorris AG Stock: price and insider trades · Switzerland · SIX SER
Track the DocMorris AG share price and the full directors' dealings record of the company, a listed equity based in Switzerland. Shares are quoted on CH CH, under the supervision of SIX SER. Operating in the Healthcare & Pharma sector, DocMorris AG has published 83 reports. The latest transaction was disclosed on 29 June 2026 (Purchase). Among the most active insiders: Anonymous (Non-executive member of the board of directors). Every trade is free.
83
Insider Decl.
0
Thresholds
€6m
68 ops.
Buy Volume
€2m
15 ops.
Sell Volume
19Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 29 June 2026
Declarations83 total
●
Anonymous (a non-executive member of the board of directors)
a non-executive member of the board of directorsExecutives(filed)
6,688 shares@ CHF 9.0313.3% of flowSIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q6T00046
Ideal exit: 26 Mar 2027 (T+270)
●
Anonymous (an executive member of the board of directors / member of senior management)
an executive member of the board of directors / member of senior managementExecutives(filed)
1,321 shares@ CHF 6.61100.0% of flowSIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q5M00027
Ideal exit: 16 Feb 2027 (T+270)
●
Anonymous (Executive member of the board of directors / member of senior management)
Executive member of the board of directors / member of senior managementExecutives
1,321 shares@ CHF 6.6050.4% of flowSIX:T1Q5M00027
Ideal exit: 16 Feb 2027 (T+270)
●
Anonymous (a non-executive member of the board of directors)
a non-executive member of the board of directorsExecutives(filed)
26,700 shares@ CHF 7.5051.3% of flowSIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q4M00053
Ideal exit: 17 Jan 2027 (T+270)
●
Anonymous (Non-executive member of the board of directors)
Non-executive member of the board of directorsExecutives
26,700 shares@ CHF 7.49794.2% of flowSIX:T1Q4M00053
Ideal exit: 17 Jan 2027 (T+270)
●
Anonymous (a non-executive member of the board of directors)
a non-executive member of the board of directorsExecutives(filed)
28,000 shares@ CHF 6.7948.7% of flowSIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q4K00024
Ideal exit: 15 Jan 2027 (T+270)
●
Anonymous (Non-executive member of the board of directors)
Non-executive member of the board of directorsExecutives
28,000 shares@ CHF 6.78754.0% of flowSIX:T1Q4K00024
Ideal exit: 15 Jan 2027 (T+270)
●
Anonymous (Executive member of the board of directors / member of senior management)
Executive member of the board of directors / member of senior managementExecutives
160 shares@ CHF 3.96190.0% of flowSIX:T1Q3O000A8
Ideal exit: 19 Dec 2026 (T+270)
●
Anonymous (Executive member of the board of directors / member of senior management)
Executive member of the board of directors / member of senior managementExecutives
2,000 shares@ CHF 4.600.5% of flowSIX:T1Q3J00044
Ideal exit: 14 Dec 2026 (T+270)
●
Anonymous (Non-executive member of the board of directors)
Non-executive member of the board of directorsExecutives
25,000 shares@ CHF 4.262.3% of flowSIX:T1Q3J00010
Ideal exit: 14 Dec 2026 (T+270)
●
Anonymous (Non-executive member of the board of directors)
Non-executive member of the board of directorsExecutives
19,800 shares@ CHF 4.101.7% of flowSIX:T1Q3J00028
Ideal exit: 14 Dec 2026 (T+270)
●
Anonymous (Executive member of the board of directors / member of senior management)
Executive member of the board of directors / member of senior managementExecutives
4,269 shares@ CHF 4.05950.9% of flowSIX:T1Q3J00069
Ideal exit: 14 Dec 2026 (T+270)
●
Anonymous (Executive member of the board of directors / member of senior management)
Executive member of the board of directors / member of senior managementExecutives
1,124 shares@ CHF 5.980.3% of flowSIX:T1PCG00060
Ideal exit: 12 Sept 2026 (T+270)
●
Anonymous (Executive member of the board of directors / member of senior management)
Executive member of the board of directors / member of senior managementExecutives
1,250 shares@ CHF 4.800.3% of flowSIX:T1PBL00047
Ideal exit: 18 Aug 2026 (T+270)
●
Anonymous (Non-executive member of the board of directors)
Non-executive member of the board of directorsExecutives
20,000 shares@ CHF 5.44272.3% of flowSIX:T1PAN00011
Ideal exit: 20 Jul 2026 (T+270)
●
Anonymous (Executive member of the board of directors / member of senior management)
Executive member of the board of directors / member of senior managementExecutives
3,400 shares@ CHF 5.931.0% of flowSIX:T1P9Q00013
Ideal exit: 23 Jun 2026 (T+270)
●
Anonymous (Executive member of the board of directors / member of senior management)
Executive member of the board of directors / member of senior managementExecutives
1,754 shares@ CHF 5.69180.5% of flowSIX:T1P9Q00021
Ideal exit: 23 Jun 2026 (T+270)
●
Anonymous (Executive member of the board of directors / member of senior management)
Executive member of the board of directors / member of senior managementExecutives
2,500 shares@ CHF 5.89350.7% of flowSIX:T1P9P00049
Ideal exit: 22 Jun 2026 (T+270)
●
Anonymous (Executive member of the board of directors / member of senior management)
Executive member of the board of directors / member of senior managementExecutives
1,550 shares@ CHF 6.0850.5% of flowSIX:T1P9G00048
Ideal exit: 13 Jun 2026 (T+270)
●
Anonymous (Executive member of the board of directors / member of senior management)
Executive member of the board of directors / member of senior managementExecutives
1,950 shares@ CHF 6.0850.6% of flowSIX:T1P9B00023
Ideal exit: 8 Jun 2026 (T+270)
●
Anonymous (Executive member of the board of directors / member of senior management)
Executive member of the board of directors / member of senior managementExecutives
5,300 shares@ CHF 6.361.7% of flowSIX:T1P6N00032
Ideal exit: 20 Mar 2026 (T+270)
●
Anonymous (Non-executive member of the board of directors)
Non-executive member of the board of directorsExecutives
7,000 shares@ CHF 6.9431.0% of flowSIX:T1P6A00013
Ideal exit: 7 Mar 2026 (T+270)
●
Anonymous (Executive member of the board of directors / member of senior management)
Executive member of the board of directors / member of senior managementExecutives
2,500 shares@ CHF 7.741.0% of flowSIX:T1P6500021
Ideal exit: 2 Mar 2026 (T+270)
●
Anonymous (Non-executive member of the board of directors)
Non-executive member of the board of directorsExecutives
6,000 shares@ CHF 8.60781.1% of flowSIX:T1P5S00033
Ideal exit: 22 Feb 2026 (T+270)
●
Anonymous (Non-executive member of the board of directors)
Non-executive member of the board of directorsExecutives
7,076 shares@ CHF 9.001.3% of flowSIX:T1P5M00077
Ideal exit: 16 Feb 2026 (T+270)
25 of 83 declarations
About DocMorris AG
DocMorris AG is a European digital health and online pharmacy group listed on the SIX Swiss Exchange (SMI/SPI) in Switzerland. The company was founded in 1993 and developed from a pharmaceutical distribution background into a digital platform focused on access to medicines, healthcare advice, and related services. Its registered office and business management headquarters are in Frauenfeld, Switzerland, reflecting its status as a Swiss-incorporated company. The group operates several e-commerce pharmacies for medical and pharmaceutical products and also provides professional health care services. Its product and service offering includes prescription medicines, over-the-counter drugs, and consumer health categories such as beauty and personal care. Strategically, DocMorris is positioning itself as a broader digital health ecosystem rather than a traditional online retailer. Its stated vision is to connect patients, doctors, pharmacies, and health insurers on a single platform, thereby expanding the company’s role beyond transactional pharmacy sales into recurring digital health services. From a competitive standpoint, DocMorris is one of the better-known pure-play online pharmacy operators in Europe. It combines a strong consumer brand with a multi-country operating footprint across Germany, the Netherlands, Spain, France, Portugal, and Switzerland. This geographic spread supports diversification, but it also exposes the company to country-specific regulation, reimbursement frameworks, and the pace of digital adoption in pharmacy and healthcare. For equity investors, that means the company’s growth profile depends not only on customer acquisition and retention, but also on regulatory execution and operational scalability. Recent developments point to a clear strategic reset toward profitability and technology-led differentiation. In 2025, DocMorris continued to emphasize qualitative growth and operational efficiency, while in 2026 it announced a partnership with Google to accelerate an AI-powered health platform. Management highlighted four focus areas: an AI health companion, an AI-enhanced online pharmacy, operational efficiency, and cloud/data security. The group also announced the closure of its Ludwigshafen site by the end of June 2026, with logistics to be integrated into its highly automated Heerlen facility. Management reaffirmed its target of reaching EBITDA break-even during 2026 and free cash flow break-even during 2027. Overall, DocMorris remains a growth-oriented healthcare technology and pharmacy platform listed in Switzerland, with improving strategic clarity but execution still central to the investment case.
